secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liminatus Pharma, Inc. (LIMN)
CIK:        0001971387
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001104659-26-012016
Event type: litigation
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liminatus Pharma issues 4M shares to settle $7.5M default judgment, dismisses lawsuits
--------------------------------------------------------------------------------

- Issued 4,000,000 shares to Clear Street LLC in exchange for surrender of 805,377 warrants.
- Settles default judgment of $7.5M plus approximately $515K interest from September 2025.
- Dismisses two federal lawsuits: Central District of California and Southern District of New York.
- Unregistered issuance under Section 3(a)(9) of the Securities Act; no commissions paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/0001104659-26-012016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/tm265593d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-012016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer